Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,959,897
in 5 filings, $33.0M under 10b5-1 plans

Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-26 Denton Sheila A. EVP & General Counsel Option exercise 10b5-1 +9,574 $58.06 $556K 39,917
2025-02-26 Denton Sheila A. EVP & General Counsel Sale 10b5-1 −9,574 $74.07 $709K 30,343
2025-02-26 Denton Sheila A. EVP & General Counsel Sale 10b5-1 −4,495 $74.08 $333K 25,848
2025-02-26 Denton Sheila A. EVP & General Counsel Option exercise · Employee Stock Option (right to buy) 10b5-1 −9,574 19,151
2025-01-31 Morrissey Michael James EVP, Head of Tech. Operations Grant or award +10,552 81,515
2025-01-31 Heeson Lee EVP, Head of Incyte Intl Grant or award +6,331 32,778
2025-01-21 Stein Steven H EVP & Chief Medical Officer Sale 10b5-1 −12,352 $72.69 $898K 66,967
2025-01-21 Morrissey Michael James EVP, Head of Tech. Operations Shares withheld for taxes −429 $73.47 $32K 70,963
2025-01-17 SWAIN PAULA J EVP, Human Resources Grant or award · Employee Stock Option (right to buy) +14,772 14,772
2025-01-17 Iyengar Vijay K EVP, GMAPPS Grant or award · Employee Stock Option (right to buy) +14,772 14,772
2025-01-17 Stamoulis Christiana EVP & Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +25,516 25,516
2025-01-17 Flannelly Barry P EVP & General Manager US Grant or award · Employee Stock Option (right to buy) +20,144 20,144
2025-01-17 Hoppenot Herve Chairman / CEO Grant or award · Employee Stock Option (right to buy) +55,510 55,510
2025-01-17 Tray Thomas Principal Accounting Officer Grant or award · Employee Stock Option (right to buy) +3,432 3,432
2025-01-17 CAGNONI PABLO J President, R&D Grant or award · Employee Stock Option (right to buy) +40,289 40,289
2025-01-17 Denton Sheila A. EVP & General Counsel Grant or award · Employee Stock Option (right to buy) +12,086 12,086
2025-01-17 Trotta Matteo EVP, GM, Dermatology US Grant or award · Employee Stock Option (right to buy) +5,371 5,371
2025-01-17 Stein Steven H EVP & Chief Medical Officer Grant or award · Employee Stock Option (right to buy) 10b5-1 +28,202 28,202
2025-01-15 Flannelly Barry P EVP & General Manager US Shares withheld for taxes −3,158 $72.46 $229K 53,374
2025-01-15 Morrissey Michael James EVP, Head of Tech. Operations Shares withheld for taxes −908 $72.46 $66K 71,392

Page 23 of 25 · 500 trades